ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

New Cancer Control Approaches May Include CCRU RFA, Center Cooperative Groups, Regional “Rounds”

March 18, 1983

Come Out of Labs and Join Picket Pines, Congressman Urges

March 30, 1990

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

May 14, 1993

Executive Summary of Centers, SPOREs Report

February 28, 2003